3 | SEC Filings Hub

Filing metadata

Accession number: 0001140361-23-050238
Form type: Form 3
Filer: Eiger BioPharmaceuticals, Inc.
CIK: CIK 1305253
Filed: Oct 30, 2023
Reporting period: Oct 18, 2023
Description: Initial ownership

Documents

0001140361-23-050238-index.htm

Complete submission

0001140361-23-050238.txt

directory listing

Filed by

Eiger BioPharmaceuticals, Inc.